Opportunity
Simpler Grants.gov #HT942526AZRPTrDA
Army Solicits Alzheimer’s Transforming Diagnosis Research Proposals
Buyer
U.S. Army Medical Research Acquisition Activity
Posted
May 01, 2026
Respond By
September 24, 2026
Identifier
HT942526AZRPTrDA
NAICS
541715
The Dept. of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is seeking research proposals for the FY26 Alzheimer’s Research Program (AZRP) Transforming Diagnosis Award (TrDA): - Solicitation supports non-incremental, solutions-oriented research to improve Alzheimer’s diagnosis, disease monitoring, and prognosis - Clinical research is allowed, but clinical trials and animal research are prohibited - Studies enrolling human subjects require preliminary data and community collaboration - Applicants are encouraged to use existing cohorts or datasets, including those with individuals 65 years or younger - A Career Initiation or Transition (CIT) Partnership Option is available, supporting collaborative research with multiple principal investigators - Approximately two awards are expected, with a total funding amount of $3.2 million - Maximum period of performance is four years per award - No specific OEMs or vendors are named, as this is a grant for research services rather than product procurement
Description
The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Diagnosis Award (TrDA) supports non-incremental, solutions-oriented research aimed at reducing or overcoming barriers to obtaining a diagnosis, meaningful disease monitoring, and accurate prognosis. Clinical research is allowed, but clinical trials and animal research are prohibited. Preliminary data and community collaboration for studies enrolling human subjects are required. The program encourages leveraging existing cohorts/datasets, including those with individuals 65 years or younger. The award includes a Career Initiation or Transition (CIT) Partnership Option for collaborative partnerships with multiple PIs.